Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 6/20 | 0.54 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.36 |
| ▸ | KIF11 | P52732 | 1/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | DRD2 | P14416 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12367411 | 0.77 | IDO1 (0.54) | IDO1HTR2ANR4A2SLC6A4APP | |
| SCHEMBL4676876 | 0.76 | IDO1 (0.50) | IDO1HTR2ANR4A2SLC6A4APP | |
| SCHEMBL12367426 | 0.74 | IDO1 (0.51) | IDO1HTR2ANR4A2SLC6A4APP | |
| SCHEMBL4676883 | 0.74 | HTR2C (0.62) | IDO1HTR2ASLC6A4APPDRD2 | |
| SCHEMBL23010845 | 0.72 | APP (0.64) | IDO1SLC6A4APPDRD2 | |
| SCHEMBL8269303 | 0.71 | HTR2A (0.51) | IDO1HTR2ANR4A2MEN1KMT2A | |
| SCHEMBL12352 | 0.70 | ATM (0.56) | IDO1HTR2ANR4A2MEN1KMT2A | |
| SCHEMBL29555842 | 0.70 | ATM (0.56) | IDO1HTR2ANR4A2MEN1KMT2A | |
| SCHEMBL17258135 | 0.70 | IDO1 (1.00) | IDO1 | |
| SCHEMBL18926994 | 0.70 | IDO1 (0.56) | IDO1HTR2ANR4A2SLC6A4APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023284837-A1 | ARYLAMINO DERIVATIVE ESTROGEN RECEPTOR MODULATOR AND USE THEREOF | 四川海思科制药有限公司 | 2023-01-19 | — | — | WO | disclosed |